Vardavas C (2020). COVID-19 and smoking: A systematic review of the evidence COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
SETH (24/03/2020). Recomendaciones control anticoagulacion-Covid-19 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Wenzhog L (2020). COVID-19 Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Gheblawi M. et al. (2020). Angiotensin Converting Enzyme 2 SARS-CoV-2 Receptor and Regulator of the Renin-Angiotensin System COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
GINA 2020 (19/03/2020). Recomendaciones medicación asma inhalada COVID19 COVID-19 y enfermedades respiratorias / 25 de Abril del 2020 Read more
Liu W et al. (2020). Analysis of factors associated with disease outcomes in hospitalized patients with 2019 novel coronavirus disease Factores de riesgo y preventivos / 25 de Abril del 2020 Read more
Sorbello M et al. (2020). The Italian coronavirus disease 2019 outbreak recommendations from clinical practice Información y materiales prácticos de ayuda para farmacéuticos (uso de equipos de protección, limpieza, recomendaciones para población....) / 25 de Abril del 2020 Read more
Tang N et al. (2020). Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Tang N. et al. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more
Vaduganathan M. et al. (2020). Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19 COVID-19 y enfermedades cardiovasculares / 25 de Abril del 2020 Read more